ADVM (Adverum Biotechnologies, Inc.) חוב לטווח קצר להון

The price trend for Adverum Biotechnologies (ADVM) shown below on the GURU.Markets platform reflects the asset's dynamics, where the indicator stands at 0.00. Adverum Biotechnologies integrates ESG principles into the development of vision treatments while adhering to bioethics. The business relies on international hazardous waste disposal standards and energy efficiency. Development is accelerating through the application of AI in DNA design and the automation of drug synthesis under physician supervision.

This indicator measures the proportion of current liabilities within the capital structure, determining the risk of emergency issuance or liability restructuring during liquidity shortages. The current ratio of short-term debt to equity stands at 0.00, which is critically important for Adverum Biotechnologies (ADVM), as the high cost of developing unique vision gene therapies requires strict control over short-term debt loads.